1 1

Molfinity

Verekitug - CAS 2768386-15-6

Verekitug - CAS 2768386-15-6

MF-0101220-01

$223.75 USD
$223.75 USD
Sale Sold out
Taxes included.
Size
View full details

Product Details

  • Bioactivity

    Verekitug is a novel, recombinant, fully human monoclonal antibody developed to selectively target thymic stromal lymphopoietin receptor (TSLPR) with high potency. Verekitug is currently being investigated as a potential therapeutic candidate for severe asthma and chronic rhinosinusitis with nasal polyps (CRSwNP), where overactivation of TSLPR contributes to disease pathology. Verekitug offers a promising approach to immune modulation in respiratory and inflammatory disease research.

  • Target

    Immunology/Inflammation related, Interleukin

  • Related Pathways

    Immunology/Inflammation

  • CAS Number

    2768386-15-6

  • Purity

    0.989

  • Storage Temperature

    -20°C

  • Shipping Conditions

    Ice Packs

  • Category

    Inhibitory Antibodies